AFFiRiS Competitors and Similar CompaniesClear all
AFFiRiS's competitors and similar companies include Bellerophon Therapeutics and Entrada Therapeutics.
 Bellerophon Therapeutics Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. |  Entrada Therapeutics Entrada Therapeutics is a biopharmaceutical company focusing on intracellular biologics. | ||
Founding Date | Founding Date 2003 | Founding Date 2009 | Founding Date 2016 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Wien, AT HQ | Locations Warren, US HQ | Locations Boston, US HQ |
Employees | Employees 3 | Employees 1715% decrease | Employees 18315% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 440.4 k | Valuation ($) 642.8 m |
Financial | |||
Net income | Net income N/A | Net income ($19.8m) (FY, 2022) | Net income ($143.8m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 34.1m | Total funding raised $ 80m | Total funding raised $ 175.6m |
For sources of this data, please see the company profile
View Company Profiles
Bellerophon Therapeutics
HQ
Warren, US
Employees
17↓ 15% decrease
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases.
View companyEntrada Therapeutics
HQ
Boston, US
Employees
183↑ 15% increase
Entrada Therapeutics is a biopharmaceutical company focusing on intracellular biologics.
View company